Skip to main content
logo
Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.3999
-0.0050 (-1.23%)
At close: Oct 26, 2026, 4:00 PM EDT
0.4299
+0.0300 (7.50%)
Pre-market: Oct 27, 2026, 4:01 AM EDT

Pasithea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1330481939
Market Cap Growth
149.61%646.69%-48.26%-58.92%-51.55%-
Enterprise Value
-3226-5-11-2318
Last Close Price
0.401.293.157.4012.8335.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----2572.20
PB Ratio
0.270.540.270.330.440.75
P/TBV Ratio
0.290.580.640.540.570.75

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----1206.82

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.000.01-
Net Debt / Equity Ratio
-0.92-1.00-0.47-0.69-0.77-1.03
Net Debt / EBITDA Ratio
2.393.440.511.062.5911.76
Net Debt / FCF Ratio
2.573.630.501.212.3616.58
Asset Turnover
-----0.00
Quick Ratio
24.8511.096.186.2217.62118.42
Current Ratio
26.2511.356.586.3418.15119.17
Return on Equity (ROE)
-65.49%-58.36%-72.84%-47.07%-24.97%-8.41%
Return on Assets (ROA)
-36.00%-27.35%-42.23%-28.02%-15.98%-10.52%
Return on Capital Employed (ROCE)
-39.70%-30.20%-95.40%-68.00%-29.10%-8.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-277.54%-68.58%-348.55%-207.04%-74.25%-5.61%
FCF Yield
-133.07%-51.07%-349.02%-174.58%-73.52%-8.25%
Buyback Yield / Dilution
-654.51%-541.47%10.64%2.83%-142.65%-41.29%
SEC Filings: 10-K · 10-Q